CapsoVision, Inc (CV): who owns it and who trades it
As of Nov 4, 2026, CV insiders reported 1 open-market sale worth $8.6K and 6 purchases worth $16M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Joanne Carol Imperial (Director), with $8.6K.
Latest filing Nov 4, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling CapsoVision
From the latest filingsOverall: more buying than selling. Funds and insiders mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CV
50 funds and institutions reported CV shares worth $39.2M at the end of Q2 2026, about 10% of the company. The largest holder is BlackRock, Inc. with 3.8%.
Funds and institutions (13F) 10%Everyone else 90%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 1.90M | 3.80% | $14.4M | +45% |
| Vanguard Capital Management LLC | 1.06M | 2.12% | $8M | +3% |
| Geode Capital Management, LLC | 578,482 | 1.16% | $4.4M | +33% |
| State Street Corp | 410,241 | 0.82% | $3.1M | +60% |
| Vanguard Portfolio Management LLC | 240,425 | 0.48% | $1.8M | +46% |
| Northern Trust Corp | 220,095 | 0.44% | $1.7M | +44% |
| Vanguard Fiduciary Trust Co | 103,630 | 0.21% | $786K | +17% |
| Charles Schwab Investment Management Inc | 79,360 | 0.16% | $602K | +29% |
| Sixth Street Partners Management Company, L.P. | 79,360 | 0.16% | $602K | New |
| Bank of New York Mellon Corp | 75,021 | 0.15% | $569K | +52% |
| Nuveen, LLC | 46,011 | 0.09% | $349K | +39% |
| Deutsche Bank Ag\ | 34,700 | 0.07% | $263K | +37% |
| XTX Topco Ltd | 31,845 | 0.06% | $241K | -53% |
| Wells Fargo & Company | 31,820 | 0.06% | $241K | +211% |
| T. Rowe Price Associates | 29,026 | 0.06% | $221K | +48% |
| Bank of America Corp | 25,469 | 0.05% | $193K | +15% |
| Rhumbline Advisers | 21,969 | 0.04% | $167K | +67% |
| MetLife Investment Management, LLC | 21,114 | 0.04% | $160K | +26% |
| Invesco Ltd. | 18,827 | 0.04% | $143K | New |
| Morgan Stanley | 18,723 | 0.04% | $142K | +25% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CV insiders reported $16M of open-market purchases and $8.6K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Eliyahou Et Al Harari | 10% owner | Purchase | 878,734 | $5.69 | $5M | Form 4 |
| Sep 18, 2026 | Eliyahou Et Al Harari | 10% owner | Purchase | 878,735 | $5.69 | $5M | Form 4 |
| Sep 15, 2026 | Ching Hang Shen | 10% owner | Purchase | 878,734 | $5.69 | $5M | Form 4 |
| Jul 17, 2026 | Eliyahou Et Al Harari | 10% owner | Purchase | 61,068 | $6.73 | $411K | Form 4 |
| Jul 8, 2026 | Eliyahou Et Al Harari | 10% owner | Purchase | 81,300 | $6.09 | $495K | Form 4 |
| Jun 26, 2026 | Eliyahou Et Al Harari | 10% owner | Purchase | 13,850 | $7.35 | $102K | Form 4 |
| Jun 8, 2026 | Joanne Carol Imperial | Director | Sale | 1,200 | $7.16 | $8.6K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Eliyahou Et Al Harari | 10% owner | $11M | – | Sep 18, 2026 |
| Ching Hang Shen | 10% owner | $5M | – | Sep 15, 2026 |
| Joanne Carol Imperial | Director | – | $8.6K | Jun 8, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CV short interest
Low short interest. 3.9% of CV shares are sold short: about 1 share in 26. Over the last 12 reports the number of shares short went up 38%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.95M CV shares were sold short, 3.9% of the shares outstanding, down 10.6% from the report before. At the average daily volume of 136,198 shares, buying them all back would take about 14.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.95M | 3.90% | -11% | 136,198 | 14.3 |
| Oct 15, 2026 | 2.18M | 4.36% | +4% | 102,765 | 21.2 |
| Sep 30, 2026 | 2.10M | 4.20% | +11% | 386,803 | 5.4 |
| Sep 15, 2026 | 1.90M | 3.79% | +1% | 162,776 | 11.7 |
| Aug 31, 2026 | 1.88M | 3.76% | +5% | 81,646 | 23.0 |
| Aug 14, 2026 | 1.79M | 3.57% | -7% | 104,306 | 17.1 |
| Jul 31, 2026 | 1.91M | 3.84% | -9% | 90,921 | 21.1 |
| Jul 15, 2026 | 2.11M | 4.23% | +23% | 162,583 | 13.0 |
| Jun 30, 2026 | 1.72M | 3.45% | +17% | 322,964 | 5.3 |
| Jun 15, 2026 | 1.47M | 2.95% | +9% | 119,920 | 12.3 |
| May 29, 2026 | 1.35M | 2.71% | -4% | 86,511 | 15.6 |
| May 15, 2026 | 1.41M | 2.83% | -1% | 101,281 | 13.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
CapsoVision company events
CapsoVision filed 11 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Sep 28, 2026.
- Sep 28, 2026AnnouncementThe Company announced that AI Highlights™, its AI-assisted reading feature for the CapsoCam Plus® system, received clearance from the U.S. Food and Drug Administration on September 25, 2026. Filing
- Sep 18, 2026AgreementCapsoVision, Inc. entered into a securities purchase agreement with certain investors, which provides for the issuance and sale, in a registered direct offering by the Company, of an aggregate of 3,163,444 shares of its common stock, par value $0.001 per share, at a purchase price of $5.69 per… Filing
- Aug 18, 2026AnnouncementAs previously announced, on August 13, 2026, CapsoVision, Inc. entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of… Filing
- Aug 13, 2026AgreementCapsoVision, Inc. entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share… Filing
- Jul 2, 2026LeadershipThe Board of Directors of CapsoVision Inc. appointed Dr. David Stanley Shields to serve as a Class I director of the Board and as a member of the Compensation Committee of the Board, in each case effective immediately to fill the vacancy upon the resignation of Dr. Imperial. Filing
- Jun 12, 2026VoteReported shareholder vote results. Filing
- May 14, 2026ResultsReleased financial results. Filing
- Mar 26, 2026ResultsReleased financial results. Filing
- Mar 20, 2026AgreementCapsoVision, Inc. entered into a Securities Purchase Agreement with selected accredited investors, for the purposes of raising approximately $14 million in aggregate gross proceeds for the Company. Filing
- Mar 13, 2026AgreementAs previously reported on Form 8-K filed by CapsoVision, Inc. on July 15, 2026, the Company entered into a development agreement with Canon Inc., a Japanese corporation, for the development of complementary metal-oxide-semiconductor image sensor samples to allow the Company to evaluate… Filing
- Dec 29, 2025AnnouncementThe Company announced submission of its 510(k) application to the Food and Drug Administration (FDA) for its proprietary AI-assisted module for CapsoCam Plus®. The press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
CapsoVision financials
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CV in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 4, 2026 | Eliyahou Harari | 13G/A | 13.2% |
| Nov 4, 2026 | Eliyahou Harari | 13G/A | 13.2% |
Questions about CapsoVision, Inc (CV) stock
Who owns the most CV stock?
The largest reported owner of CapsoVision, Inc (CV) is BlackRock, Inc., with 3.8% of the company. In total, 50 funds and institutions reported holding CV at the end of Q2 2026, together about 10% of the shares. See the largest owners.
Are CV insiders buying or selling?
In the last 12 months, CV insiders reported 6 open-market purchases worth $16M and 1 sale worth $8.6K. The latest trade was on Sep 18, 2026. See every trade.
What is the short interest in CV?
As of Oct 30, 2026, 1.95M CV shares were sold short, 3.9% of the shares outstanding, down 10.6% from the report before. At the average daily volume of 136,198 shares, buying them all back would take about 14.3 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.